newscontact us

ThermoGenesis Signs Direct Supply Agreement With Cord Blood Registry

RANCHO CORDOVA, Calif., Jan. 8, 2014 (GLOBE NEWSWIRE) — ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling technologies for the processing and storage of stem cells and other biological tissues, today announced the signing of a five-year agreement to supply Cord Blood Registry® (CBR®), the world’s largest and most experienced newborn stem cell company, with ThermoGenesis’ AutoXpress® System (AXP) cord blood processing system and disposables. The AXP System is a proprietary family of automated devices with companion sterile blood processing disposables for harvesting cord blood stem cells in closed systems. Previously, ThermoGenesis supplied CBR the AXP System indirectly through its North American independent distributor.

010814 CBR Press Release Final